Works by Münch, Götz

Results: 18

Minimal Collagen-Binding Epitope of Glycoprotein VI in Human and Mouse Platelets.

Published in:

Biomedicines, 2023, v. 11, n. 2, p. 423, doi. 10.3390/biomedicines11020423

By:

Han, Chao;
Ren, Pengxuan;
Mamtimin, Medina;
Kruk, Linus;
Sarukhanyan, Edita;
Li, Chenyu;
Anders, Hans-Joachim;
Dandekar, Thomas;
Krueger, Irena;
Elvers, Margitta;
Goebel, Silvia;
Adler, Kristin;
Münch, Götz;
Gudermann, Thomas;
Braun, Attila;
Mammadova-Bach, Elmina

Publication type:

Article

The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-77934-x

By:

Alberti, Sara;
Zhang, Qianqian;
D'Agostino, Ilaria;
Bruno, Annalisa;
Tacconelli, Stefania;
Contursi, Annalisa;
Guarnieri, Simone;
Dovizio, Melania;
Falcone, Lorenza;
Ballerini, Patrizia;
Münch, Götz;
Yu, Ying;
Patrignani, Paola

Publication type:

Article

Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.

Published in:

FASEB Journal, 2004, v. 18, n. 2, p. 397, doi. 10.1096/fj.03-0464fje

By:

Massberg, Steffen;
Konrad, Ildiko;
Bültmann, Andreas;
Schulz, Christian;
Münch, Götz;
Peluso, Mario;
Lorenz, Michael;
Schneider, Simon;
Besta, Felicitas;
Müller, Iris;
Bin Hu;
Langer, Harald;
Kremmer, Elisabeth;
Rudelius, Martina;
Heinzmann, Ulrich;
Ungerer, Martin;
Gawaz, Meinrad

Publication type:

Article

Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke.

Published in:

Heart International, 2016, v. 11, n. 1, p. e10, doi. 10.5301/heartint.5000229

By:

Reimann, Andreas;
Li, Zhongmin;
Goebel, Silvia;
Fassbender, Julia;
Holthoff, Hans-Peter;
Gawaz, Meinrad;
Münch, Götz;
Ungerer, Martin

Publication type:

Article

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201160

By:

Boivin-Jahns, Valérie;
Uhland, Kerstin;
Holthoff, Hans-Peter;
Beyersdorf, Niklas;
Kocoski, Vladimir;
Kerkau, Thomas;
Münch, Götz;
Lohse, Martin J.;
Ungerer, Martin;
Jahns, Roland

Publication type:

Article

Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Published in:

Clinical Reviews in Allergy & Immunology, 2017, v. 52, n. 2, p. 182, doi. 10.1007/s12016-016-8562-7

By:

Ungerer, Martin;
Faßbender, Julia;
Li, Zhongmin;
Münch, Götz;
Holthoff, Hans-Peter

Publication type:

Article

Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.

Published in:

British Journal of Pharmacology, 1998, v. 125, n. 1, p. 41, doi. 10.1038/sj.bjp.0702034

By:

Brixius, Klara;
Mohr, Valeska;
Müller-Ehmsen, Jochen;
Hoischen, Susanne;
Münch, Götz;
Schwinger, Robert H G

Publication type:

Article

The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE−/− mice.

Published in:

Cardiovascular Research, 2008, v. 80, n. 1, p. 131, doi. 10.1093/cvr/cvn169

By:

Schönberger, Tanja;
Siegel-Axel, Dorothea;
Bußl, Renate;
Richter, Sabine;
Judenhofer, Martin S.;
Haubner, Roland;
Reischl, Gerald;
Klingel, Karin;
Münch, Götz;
Seizer, Peter;
Pichler, Bernd J.;
Gawaz, Meinrad

Publication type:

Article

Myocardial Technetium-99m-Tetrofosmin and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery Disease.

Published in:

Journal of Nuclear Medicine, 1997, v. 38, n. 3, p. 428

By:

Münch, Götz;
Neverve, Jodi;
Matsunari, Ichiro;
Schröter, Gerrit;
Schwaiger, Markus

Publication type:

Article

cAMP-Dependent Protein Kinase A-Stimulated Sarcoplasmic Reticulum Function in Heart Failurea.

Published in:

Annals of the New York Academy of Sciences, 1998, v. 853, n. 1, p. 240, doi. 10.1111/j.1749-6632.1998.tb08272.x

By:

SCHWINGER, ROBERT H. G.;
BÖLCK, BIRGIT;
MÜNCH, GÖTZ;
BRIXIUS, KLARA;
MÜLLER-EHMSEN, JOCHEN;
ERDMANN, ERLAND

Publication type:

Article

Corrigendum to ‘Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-b1-adrenergic receptor antibody neutralization and of immune parameters’ [Eur J Heart Fail 2012;14:1230–1239].

Published in:

2013

By:

Münch, Götz;
Boivin ‐ Jahns, Valerie;
Holthoff, Hans ‐ Peter;
Adler, Kristin;
Lappo, Mariola;
Truöl, Stephan;
Degen, Heidrun;
Steiger, Nina;
Lohse, Martin J.;
Jahns, Roland;
Ungerer, Martin

Publication type:

Erratum

Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parameters.

Published in:

European Journal of Heart Failure, 2012, v. 14, n. 11, p. 1230

By:

Münch, Götz;
Boivin-Jahns, Valerie;
Holthoff, Hans-Peter;
Adler, Kristin;
Lappo, Mariola;
Truöl, Stephan;
Degen, Heidrun;
Steiger, Nina;
Lohse, Martin J.;
Jahns, Roland;
Ungerer, Martin

Publication type:

Article

Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

Published in:

Journal of Molecular Medicine, 2010, v. 88, n. 9, p. 909, doi. 10.1007/s00109-010-0629-y

By:

Daub, Karin;
Siegel-Axel, Dorothea;
Schönberger, Tanja;
Leder, Christoph;
Seizer, Peter;
Müller, Karin;
Schaller, Martin;
Penz, Sandra;
Menzel, Dagmar;
Büchele, Berthold;
Bültmann, Andreas;
Münch, Götz;
Lindemann, Stephan;
Simmet, Thomas;
Gawaz, Meinrad

Publication type:

Article

The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071193

By:

Ungerer, Martin;
Li, Zhongmin;
Baumgartner, Christine;
Goebel, Silvia;
Vogelmann, Jasmin;
Holthoff, Hans-Peter;
Gawaz, Meinrad;
Münch, Götz

Publication type:

Article

The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke.

Published in:

PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0066960

By:

Goebel, Silvia;
Li, Zhongmin;
Vogelmann, Jasmin;
Holthoff, Hans-Peter;
Degen, Heidrun;
Hermann, Dirk M.;
Gawaz, Meinrad;
Ungerer, Martin;
Münch, Götz

Publication type:

Article

Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits.

Published in:

Heart International, 2012, v. 7, n. 2, p. 57

By:

Münch, Götz;
Bültmann, Andreas;
Zhongmin Li;
Holthoff, Hans-Peter;
Ullrich, Julia;
Wagner, Silvia;
Ungerer, Martin

Publication type:

Article

ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.

Published in:

2017

By:

Degen, Heidrun;
Borst, Oliver;
Ziegler, Melanie;
Mojica Munoz, Ann‐Katrin;
Jamasbi, Janina;
Walker, Britta;
Göbel, Silvia;
Fassbender, Julia;
Adler, Kristin;
Brandl, Richard;
Münch, Götz;
Lorenz, Reinhard;
Siess, Wolfgang;
Gawaz, Meinrad;
Ungerer, Martin

Publication type:

journal article

The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR-/-/ApoBec-/- Mice.

Published in:

Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2019, v. 52, n. 4, p. 681, doi. 10.33594/000000048

By:

Zeibig, Stephan;
Büttcher, Manuela;
Goebel, Silvia;
Pauli, Jessica;
Hunger, Annique;
Ungerer, Martin;
Gawaz, Meinrad;
Münch, Götz

Publication type:

Article

Works by Münch, Götz

Minimal Collagen-Binding Epitope of Glycoprotein VI in Human and Mouse Platelets.

The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia.

Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.

Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke.

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.

Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.

The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE−/− mice.

Myocardial Technetium-99m-Tetrofosmin and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery Disease.

cAMP-Dependent Protein Kinase A-Stimulated Sarcoplasmic Reticulum Function in Heart Failure<sup>a</sup>.

Corrigendum to ‘Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-b1-adrenergic receptor antibody neutralization and of immune parameters’ [Eur J Heart Fail 2012;14:1230–1239].

Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parameters.

Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times.

The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke.

Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits.

ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.

The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR<sup>-/-</sup>/ApoBec<sup>-/-</sup> Mice.